Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sulzer Medica to license carbon technology to ATS

This article was originally published in Clinica

Executive Summary

ATS Medical is to buy a technology licence from Sulzer Medica's subsidiary Sulzer Carbomedics for $41 million to manufacture the pyrolytic carbon and metal components for the ATS mechanical heart valve. ATS will continue to buy components, at a reduced level, from Sulzer Carbomedics under an OEM agreement until the end of 2007. "We have recognised for a long period of time that it would be necessary to control our destiny and make our own carbon if we are to accomplish our goal of being number one in the heart valve business," said Manny Villafana, chairman and CEO of ATS.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073009

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel